Publications by authors named "Shoko Yoshimura"
Low Urin Tract Symptoms
November 2024
Article Synopsis
- The study aimed to assess the safety and effectiveness of vibegron, a drug for treating overactive bladder (OAB), in Japanese patients through a real-world clinical trial over four years.
- Out of 1848 patients, 154 adverse drug reactions (ADRs) were reported, with common side effects including increased urine volume, constipation, and urinary retention, particularly affecting older male patients.
- The drug demonstrated an effectiveness rate of 88.8%, with significant improvements in OAB symptoms observed across all patient groups, making vibegron a valuable option for OAB treatment.
